Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)

Clinical trial NCT02167035 · COMPLETED

Trial details

NCT number: NCT02167035
Sponsor: Cornerstone Health Care, PA
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2014-08-01
Primary completion: 2018-03-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.